Sotera Health (NASDAQ:SHC) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Sotera Health (NASDAQ:SHC) have been given a consensus rating of “Moderate Buy” by the six research firms that are covering the stock, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $15.70.

Several analysts have commented on SHC shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research report on Tuesday, August 6th. Barclays lifted their price target on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a report on Tuesday, August 6th.

Sotera Health Stock Performance

SHC stock opened at $16.83 on Wednesday. The company has a quick ratio of 2.59, a current ratio of 2.93 and a debt-to-equity ratio of 5.46. The firm has a market cap of $4.76 billion, a PE ratio of 88.58 and a beta of 2.06. The business has a 50 day moving average of $15.04 and a 200-day moving average of $12.88. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.04. The firm had revenue of $277.00 million during the quarter, compared to analyst estimates of $266.45 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The business’s revenue was up 8.6% compared to the same quarter last year. During the same period last year, the firm posted $0.19 EPS. As a group, sell-side analysts expect that Sotera Health will post 0.64 earnings per share for the current year.

Insider Transactions at Sotera Health

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the sale, the director now directly owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 55.12% of the company’s stock.

Institutional Investors Weigh In On Sotera Health

Institutional investors have recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. increased its position in shares of Sotera Health by 1.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 898,320 shares of the company’s stock valued at $15,137,000 after buying an additional 16,401 shares during the period. Dimensional Fund Advisors LP increased its holdings in Sotera Health by 22.3% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,992,717 shares of the company’s stock worth $33,581,000 after acquiring an additional 363,628 shares during the period. Norges Bank purchased a new stake in Sotera Health in the 4th quarter worth approximately $16,432,000. Quest Partners LLC bought a new position in Sotera Health in the 4th quarter valued at $139,000. Finally, TD Asset Management Inc grew its position in shares of Sotera Health by 10.7% during the 4th quarter. TD Asset Management Inc now owns 90,538 shares of the company’s stock valued at $1,526,000 after purchasing an additional 8,738 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.